Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 52% ± 18% | |
lung | 15 studies | 51% ± 17% | |
intestine | 11 studies | 43% ± 20% | |
kidney | 8 studies | 49% ± 15% | |
brain | 7 studies | 27% ± 8% | |
eye | 7 studies | 38% ± 14% | |
bone marrow | 5 studies | 39% ± 16% | |
lymph node | 4 studies | 50% ± 14% | |
uterus | 4 studies | 59% ± 12% | |
breast | 4 studies | 57% ± 4% | |
liver | 4 studies | 55% ± 21% | |
pancreas | 3 studies | 56% ± 25% | |
placenta | 3 studies | 63% ± 15% | |
prostate | 3 studies | 41% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 5953.16 | 258 / 258 | 100% | 266.14 | 230 / 230 |
esophagus | 100% | 6842.28 | 1445 / 1445 | 100% | 228.15 | 183 / 183 |
liver | 100% | 6203.71 | 226 / 226 | 100% | 236.63 | 406 / 406 |
ovary | 100% | 7235.18 | 180 / 180 | 100% | 523.11 | 430 / 430 |
pancreas | 100% | 3764.76 | 328 / 328 | 100% | 253.93 | 178 / 178 |
skin | 100% | 7260.65 | 1809 / 1809 | 100% | 261.92 | 472 / 472 |
thymus | 100% | 6094.17 | 653 / 653 | 100% | 306.55 | 605 / 605 |
uterus | 100% | 7209.25 | 170 / 170 | 100% | 361.39 | 459 / 459 |
brain | 100% | 5514.38 | 2640 / 2642 | 100% | 278.65 | 705 / 705 |
intestine | 100% | 7518.42 | 966 / 966 | 100% | 297.68 | 526 / 527 |
prostate | 100% | 6967.86 | 245 / 245 | 100% | 282.87 | 501 / 502 |
kidney | 100% | 6425.44 | 89 / 89 | 100% | 202.62 | 899 / 901 |
bladder | 100% | 7259.05 | 21 / 21 | 100% | 309.98 | 502 / 504 |
lung | 100% | 6409.99 | 578 / 578 | 100% | 213.87 | 1150 / 1155 |
breast | 100% | 7362.13 | 459 / 459 | 99% | 245.09 | 1111 / 1118 |
stomach | 100% | 5595.28 | 359 / 359 | 99% | 274.26 | 284 / 286 |
adipose | 100% | 7287.40 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 353.13 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 534.21 | 29 / 29 |
spleen | 100% | 8210.13 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 298.28 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 512.26 | 1 / 1 |
blood vessel | 100% | 7177.06 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 4312.82 | 856 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 6791.58 | 922 / 929 | 0% | 0 | 0 / 0 |
muscle | 99% | 4078.77 | 796 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016075 | Biological process | rRNA catabolic process |
GO_0008409 | Molecular function | 5'-3' exonuclease activity |
GO_0005515 | Molecular function | protein binding |
GO_0008408 | Molecular function | 3'-5' exonuclease activity |
GO_0003723 | Molecular function | RNA binding |
Gene name | TRIR |
Protein name | Telomerase RNA component interacting RNase Telomerase RNA component interacting RNase (EC 3.1.13.-) (Exoribonuclease TRIR) |
Synonyms | C19orf43 |
Description | FUNCTION: Exoribonuclease that is part of the telomerase RNA 3' end processing complex and which has the ability to all four unpaired RNA nucleotides from 5' end or 3' end with higher efficiency for purine bases . . |
Accessions | ENST00000588213.1 Q9BQ61 K7ELS0 ENST00000242784.5 K7EN60 K7ERU7 ENST00000591254.1 ENST00000592273.5 |